Federal Medical Centre, Yola, Nigeria.
Cepheid, Sunnyvale, CA 94040, USA.
J Glob Antimicrob Resist. 2020 Jun;21:42-45. doi: 10.1016/j.jgar.2019.08.017. Epub 2019 Aug 28.
This study aimed to identify carbapenem-resistant Gram-negative bacteria from clinical specimens of patients in Yola, Nigeria.
Routine clinical specimens were screened for the presence of carbapenem-resistant Gram-negative bacteria using chromogenic agar plates. Susceptibility of all presumptive isolates to carbapenems was tested by MIC and disk diffusion methods. Real-time PCR was used to test for the presence of carbapenemase genes.
Screening of 1741 clinical specimens yielded 119 (6.8%) presumptive carbapenem-resistant Gram-negative bacteria. Antimicrobial susceptibility testing confirmed carbapenem resistance in 105 of these isolates. New Delhi metallo-β-lactamase (bla) gene was detected in 26 isolates and Verona integron-encoded metallo-β-lactamase (bla) gene was detected in four. The mechanism of resistance could not be identified in approximately two thirds of the carbapenem-resistant isolates.
While bla and bla accounted for 28.6% of the resistance seen, further molecular-based studies are needed to characterise the other mechanisms of carbapenem resistance in these isolates.
本研究旨在从尼日利亚约拉的患者临床标本中鉴定出碳青霉烯类耐药革兰氏阴性菌。
使用显色琼脂平板对常规临床标本进行碳青霉烯类耐药革兰氏阴性菌的筛查。采用 MIC 和纸片扩散法检测所有疑似分离株对碳青霉烯类药物的敏感性。实时 PCR 用于检测碳青霉烯酶基因的存在。
对 1741 份临床标本进行筛查,得到 119 株(6.8%)疑似碳青霉烯类耐药革兰氏阴性菌。对这些分离株中的 105 株进行了抗菌药物敏感性测试,证实对碳青霉烯类药物耐药。在 26 株分离株中检测到新德里金属β-内酰胺酶(bla)基因,在 4 株中检测到 Verona 整合子编码的金属β-内酰胺酶(bla)基因。大约三分之二的碳青霉烯类耐药分离株无法确定其耐药机制。
虽然 bla 和 bla 基因分别占所观察到的耐药性的 28.6%,但需要进一步的基于分子的研究来描述这些分离株中碳青霉烯类耐药的其他机制。